Markets

Kenvue Inc

stock
KVUE· NYSE· Consumer Staples

17.83

+0.13 (+0.73%)

Closed 12 Oct, 21:00

1 Sept8 Sept14 Sept18 Sept24 Sept30 Sept6 Oct12 Oct17.0517.618.1518.719.25
62

Good Money Guide Pro Score

Attractive

Attractive investment profile

Technical Analysis

Short-Term Outlook

Bearish

1 bull · 2 bear · 2 neutral

Medium-Term Outlook

Bearish

1 bull · 3 bear · 0 neutral

Moving Average (50d)
Bearish
18.39

Price below 50-day MA

Moving Average (200d)
Bearish
18.05

Price below 200-day MA

EMA (12d)
Bearish
17.67

Price below 12-day EMA

EMA (26d)
Bearish
17.86

Price below 26-day EMA

RSI (14)
Neutral
44.6

Neutral momentum zone

MACD
Bullish
-0.19

MACD above signal line

Stochastic Oscillator
Bearish
54.3%

%K below %D

Bollinger Bands
Neutral
17.67

Price near middle band

Standard Deviation
Neutral
0.20

Volatility measure — informational only

Volume Indicators

On Balance Volume (OBV)

30 Jul13 Aug28 Aug14 Sept29 Sept0250.0M500.0M1.0B

Volume Accumulation Distribution (VAD)

30 Jul13 Aug28 Aug14 Sept29 Sept-1300000000-1200000000-1100000000-900000000

Market Statistics

Open

17.66

Day High

17.83

Day Low

17.49

Previous Close

17.70

Day Range

17.49 - 17.83

Volume

20.29M

Day Change

+0.13

Market Cap

36441764000

Exchange

NYSE

Sector

Consumer Staples

Last Updated

2026-10-12

Fundamentals

Rate limit reached. Please try again in a minute.

Analyst Forecast

Rate limit reached. Please try again in a minute.

Fundamental Analysis

Unable to load fundamental data

Learn about Kenvue Inc

What is Kenvue Inc?

Kenvue Inc. is a global consumer health company that owns well-known household brands like Tylenol, Listerine, and Neutrogena. Formerly the consumer health division of Johnson & Johnson, it operates as an independent entity focused on developing and marketing science-backed self-care products for personal wellness.

Is Kenvue Inc a good investment?

Kenvue offers the stability of essential consumer products, which often perform reliably even during economic downturns, and provides a steady dividend for income-focused investors. However, the company faces significant competition in the retail market and potential legal challenges related to its legacy product portfolios. Please remember that this information is for educational purposes only and does not constitute financial advice.

How do you invest in Kenvue Inc?

To invest in Kenvue, you can purchase shares directly through a regulated online stockbroker or a trading app that offers access to the New York Stock Exchange where it trades under the ticker symbol KVUE. Many investors also gain exposure to the company through broad-market index funds or consumer-staple-focused exchange-traded funds (ETFs).

Educational content generated by AI — not financial advice.

Time & Sales

No trades yet.

News & Sentiment

Kimberly-Clark (KMB) Secures Consents for Kenvue Notes Amendments in $7 Billion Exchange Offer

GuruFocus· 13 Oct 15:01· Somewhat-Bullish

Kimberly-Clark (KMB) announced it has secured the necessary consents for amendments to Kenvue Notes as part of its $7 billion exchange offer. This development is a key step towards Kimberly-Clark's pending acquisition of Kenvue, with the settlement of the exchange offers expected after the acquisition closes, likely not before November 2, 2026. The amendments eliminate most restrictive covenants and certain events of default for the Kenvue Notes.

Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up

WSJ· 13 Oct 14:42· Somewhat-Bullish

Kimberly-Clark's $40 billion bid for Kenvue has received conditional approval from the European Union. This approval came after Kimberly-Clark offered to divest its tampon and feminine hygiene brands in the European Economic Area. The European Commission stated that this addresses concerns about potential hindrance to competition in tampon markets in Czech Republic, Estonia, and Slovakia.

EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions

Reuters· 13 Oct 14:16· Somewhat-Bullish

The European Commission has approved Kimberly-Clark's acquisition of Kenvue, contingent on Kimberly-Clark divesting its tampon and other feminine hygiene brands within the European Economic Area. This measure addresses EU antitrust concerns, ensuring market competition. The brands to be sold include Kotex, Camelia, and Record.

Kimberly-Clark secures consents, offers up to $7B in exchange for Kenvue notes

TradingView· 13 Oct 11:38· Somewhat-Bullish

Kimberly-Clark announced it has secured the necessary consents to amend the indentures for all outstanding Kenvue notes, based on early tenders. The company is offering to exchange these Kenvue notes for up to $7.0 billion of new Kimberly-Clark notes and cash. These amendments will remove most restrictive covenants and certain default events, with settlement expected promptly after expiration, likely aligning with the acquisition of Kenvue.

Kenvue Implements Third Supplemental Indenture, Easing Covenants for Kimberly-Clark's $7 Billion Note Exchange

TradingView· 13 Oct 11:32· Neutral

Kenvue has signed a Third Supplemental Indenture to modify its 2023 base indenture, facilitating Kimberly-Clark's exchange offers for up to $7.0 billion of Kenvue notes. This amendment removes most restrictive covenants, certain events of default, SEC reporting requirements, and some merger/asset transfer restrictions. The changes become active for each note series upon the settlement of its related exchange offer, anticipated around the Kimberly-Clark acquisition closing.

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

TradingView· 13 Oct 10:59· Bullish

Kimberly-Clark announced the successful completion of its consent solicitations for Kenvue Notes and an amendment to the terms of its exchange offers. This news, distributed via PR Newswire, indicates progress on financial arrangements related to Kenvue notes. The announcement is a headline-only item, suggesting a formal update on corporate financial actions.

Form 4 Kenvue Inc For: 11 October By Investing.com

Investing.com UK· 11 Oct 20:08· Neutral

This article announces the filing of Form 4 for Kenvue Inc. on October 11, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders whenever they trade their company's stock. The article itself contains minimal textual content beyond the headline.

Form 4 Kenvue Inc For: 11 October By Investing.com

Investing.com South Africa· 11 Oct 09:32· Neutral

This article from Investing.com reports on a Form 4 filing for Kenvue Inc. on October 11, 2026. Form 4 filings are legally required documents by the U.S. Securities and Exchange Commission (SEC) that must be filed by company insiders, such as officers, directors, or beneficial owners, whenever they trade securities in their own company. The article provides the filing date and company name, indicating an insider transaction occurred.

Form 4 Kenvue Inc For: 11 October By Investing.com

Investing.com South Africa· 11 Oct 08:38· Neutral

This article from Investing.com reports on the filing of Form 4 for Kenvue Inc. on October 11, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in their ownership of company stock. The article provides the title and date of the filing, along with a minor stock performance detail for KVUE.

Form 4 Kenvue Inc For: 11 October By Investing.com

Investing.com Nigeria· 11 Oct 07:38· Neutral

This article from Investing.com announces the filing of Form 4 for Kenvue Inc. on October 11, 2026. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders whenever they trade shares in their own company. The article provides the title and date of the filing, along with the stock symbol KVUE.

Share your opinion

Log in or sign up to share your opinion.

Sign up

Community Discussion

No posts yet for KVUE — be the first to start the discussion.

Trade

Log in or sign up to place simulated trades.

Sign up

Point & Figure Analysis

OHLC

O: 17.58
H: 17.74
L: 17.44
C: 17.73
V: 23,267,300

Signals

as of 08 Oct 2026
TrendBear
RelativeBear ▼
Strength
Last Climax (BUY)(07 Jul 2026)
Last Climax (SELL)(07 Apr 2026)
Last KDR (BOUNCE)(30 Sept 2026)
Last POS (REVERSAL)(01 Oct 2026)
Last MA Crossover(DEATH) 24 Sept 2026

Targets

Bear to:17.00 ▼
Stop loss at:18.00

© 2026 Good Money Guide Pro. All rights reserved.

All content copyright Good Money Guide Pro. Good Money Guide Pro is a registered trademark and is owned and operated by RJBCO Ltd. Registered in England & Wales, Company Number: 07134687. Registered office at 11 Old Bond Street, Mayfair, London W1S 4PN. VAT registration number: 324242143. Data protection registration number: ZA468875.

The information contained in this website is for informational purposes only and does not constitute financial advice. The material does not contain (and should not be construed as containing) investment advice or an investment recommendation, or, an offer of or solicitation for, a transaction in any financial instrument.